Expanded Access to Provide ARQ 092 for the Treatment of Overgrowth Diseases and/or Vascular Anomalies

Proteus syndrome

ArQule – Proteus Syndrome

Informed Consent for Whole Genome Sequencing: Ideals and Norms Referenced by Early Participants Study of Proteus Syndrome and Related Congenital Disorders A Multi-Cohort Phase 2 Dose-Escalation Study of ARQ 092 (Miransertib) in Proteus Syndrome Dose Finding Trial of ARQ 092 in Children and Adults With Proteus Syndrome Expanded Access to Provide ARQ 092 for the Treatment of Overgrowth Diseases and/or Vascular Anomalies